Compare Enveric Biosciences Inc (ENVB) vs State Street Technology Select Sector SPDR ETF (XLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs State Street Technology Select Sector SPDR ETF — how do they compare? Enveric Biosciences Inc trades at $1.56 (market cap $6.20M), while State Street Technology Select Sector SPDR ETF trades at $188.82. The key difference: State Street Technology Select Sector SPDR ETF is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | XLK | |
|---|---|---|
Market Cap | $6.20M | — |
Sector | Health | Sector/Thematic |
52-Week High | $17.40 | $198.21 |
52-Week Low | $1.27 | $127.49 |
Enterprise Value | $1.30M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.56, up 1.3% on the day, with a bullish technical signal from moving averages and strong analyst support (75% buy ratings). The company reported four consecutive quarterly earnings beats in 2025, including a positive EPS of $0.85 in Q4, while recent news highlights progress in preclinical studies for its non-hallucinogenic psychiatric drug candidate EB-003.
Despite operational losses and negative ROE/ROA, ENVB's consistent earnings surprises and advancing pipeline present speculative growth potential. Key risks include cash burn, clinical trial outcomes, and regulatory hurdles, requiring careful risk assessment by investors.
XLK trades at $188.97, up 1.42% on the day, with a bullish technical signal from moving averages and strong sector inflows. The technology sector is benefiting from robust earnings and AI-driven growth, though the ETF faces competition from alternatives like IGM that offer broader exposure at lower valuations. Recent news highlights record inflows into tech ETFs and strong corporate earnings, particularly from key holdings like Microsoft.
Outlook remains positive given sector momentum and earnings strength, but risks include high concentration in mega-cap stocks and potential valuation concerns. The ETF's performance is closely tied to a few large constituents, making diversification a key consideration for investors seeking tech exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About State Street Technology Select Sector SPDR ETF
XLK tracks the Technology Select Sector Index, providing targeted exposure to the largest and most influential technology companies within the S&P 500. It is a highly concentrated, liquid vehicle focused on software, semiconductors, and hardware leaders, serving as the primary benchmark for U.S. large-cap technology performance.
Read more on XLK →
